Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/ADPT
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Adaptive Biotechnologies Corp (ADPT) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

ADPT trades at $26.25, up 2.74% today and near its 52-week high. The stock shows bullish technical momentum with improving fundamentals as revenue grew 55% year-over-year to $277M in 2025, while net losses narrowed significantly from -$159M to -$59M. The company's strategic separation of its MRD and Immune Medicine businesses aims to unlock value, with MRD revenue growing 49% year-over-year. Analyst consensus remains positive with 65% buy ratings and a $25.50 price target.
ADPT presents a turnaround story with strong revenue growth and margin improvement, though profitability remains elusive. The business separation could drive valuation upside, but execution risks and continued losses warrant caution. Near-term catalysts include Q3 earnings and MRD business performance, while high valuation multiples and institutional selling pressure pose headwinds.
Read full analysis

Key Stats

  • Market Cap
    $4.18B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $26.25
  • 52W Low
    $12.41
  • Typical Hold Time
    -
  • Enterprise Value
    $4.24B
  • Div Yield
    -
  • Trading Activity
    -
$26.77
52W Low: $12.41
27 Mar 2026
52W High: $26.77
27 Aug 2026

Track Adaptive Biotechnologies Corp (ADPT) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Adaptive Biotechnologies Corp has traded between a low of $12.41 and a high of $26.77, highlighting its annual price range. Buy and sell Adaptive Biotechnologies Corp shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Adaptive Biotechnologies Corp

Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.

Most Recent News

Content is generated by Aura AI

Toast's CRO sells nearly 14,000 shares amid 50% stock rise in 3 months

Toast's Chief Revenue Officer has sold nearly 14,000 shares as the company's stock price has surged over 50% in the past three months. This insider sale comes at a time when investor confidence appears strong, reflecting positive market sentiment tow...

Market News
3 hours ago
Catie Hogan
Bullish
news icon
pluang ai news

Kohl's Q2 EPS beats estimates on tariff refunds despite 18th straight quarter of sales decline

Kohl's reported a strong adjusted EPS of $1.28 for Q2, more than doubling analyst expectations due to a 43% gross margin boosted by one-time tariff refunds. However, the retailer's total revenue and comparable sales fell by 0.9%, marking the 18th con...

Company Fundamentals
3 hours ago
Stuart Mooney
Neutral
pluang ai news

100+ tech firms urge public-private cooperation to fight rising AI-driven cyberattacks.

Over 100 leading tech companies, including OpenAI, Google, Microsoft, and cybersecurity firms like Crowdstrike, have signed an open letter calling for joint efforts between private and public sectors to combat increasing AI-enabled cyber threats. The...

Market News
4 hours ago
TechCrunch
Neutral
pluang ai news
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $4.18B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $26.25
  • 52W Low
    $12.41
  • Typical Hold Time
    -
  • Enterprise Value
    $4.24B
  • Div Yield
    -
  • Trading Activity
    -
$26.77
52W Low: $12.41
27 Mar 2026
52W High: $26.77
27 Aug 2026

Track Adaptive Biotechnologies Corp (ADPT) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Adaptive Biotechnologies Corp has traded between a low of $12.41 and a high of $26.77, highlighting its annual price range. Buy and sell Adaptive Biotechnologies Corp shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!